en · de · es · fr · pt
thymosin-alpha-1-notes.peptides5388.com › Guide › Identity And Molecular Background — What the Evidence Shows

Identity And Molecular Background — What the Evidence Shows

By Editorial Desk · published 2026-03-30 · last reviewed 2026-05-20 · Guide

acetylated peptide comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Updated 2026-05-20. Numbers and descriptions here follow the published literature rather than marketing material.

Identity and Molecular Background

The peptide occurs naturally in thymic tissue and has been detected in serum and other biological fluids. Reported concentrations are low, and reliable measurement generally requires immunoassay or mass spectrometry with an enrichment step. It is released from a larger precursor, prothymosin alpha, by proteolytic cleavage, although the enzymes involved are not fully characterized. Whether circulating levels reflect thymic output specifically remains an open question.

Thymosin alpha 1 is a 28-amino-acid peptide first isolated from thymosin fraction 5, a bovine thymic extract. Its sequence begins with an acetylated serine residue and carries a high proportion of acidic residues, so the molecule has a net negative charge near neutral pH. Despite the shared name, it is unrelated in sequence to the thymosin beta family. Synthetic material prepared by solid-phase peptide synthesis is identical in sequence to the natural peptide.

Several names appear in the literature for this peptide, including thymalfasin and the abbreviation T-alpha-1. Naming conventions differ among research articles, regulatory documents, and supplier catalogs, which complicates literature searches. Both synthetic and recombinant production routes yield a peptide with the same 28-residue sequence as the thymic isolate. Because the thymosin label also covers unrelated peptides, sources should be compared by sequence rather than by name alone.

分子身份与天然来源

市售的胸腺素α1通常以冻干粉形式提供,溶解后用于注射。其氨基酸组成包括多个酸性残基,因此在中性pH下带负电荷。该肽可溶于水和生理盐水,但在有机溶剂中溶解度有限。储存条件通常为冻干状态下负20摄氏度,溶解后需冷藏并避免反复冻融。常见的同义词包括胸腺肽α1、thymalfasin和Tα1。

胸腺素α1(thymosin alpha 1,Tα1)是一种由28个氨基酸组成的酸性肽,N端被乙酰化,分子量约为3108道尔顿。该肽最早从牛胸腺组织提取物中分离,属于胸腺素组分5的一个成分。其序列在不同哺乳动物中高度保守,提示其具有基本的生物学功能。名称中的“α1”指其在电泳中的迁移位置,并非表示亚型编号。它既存在于胸腺,也存在于脾脏和淋巴结等免疫组织。

Thymosin-alpha-1 at a glance

PropertyValueNotes
Molecular formulaC129H215N33O55Calculated for the acetylated 28-residue peptide
AppearanceWhite to off-white powderLyophilized solid recovered from aqueous buffer
SolubilityFreely soluble in waterTypically dissolved in water or buffer before use
Typical storage-20 C or below, desiccatedProtect from light and avoid repeated freeze-thaw cycles
Identity testingReverse-phase HPLC with mass spectrometryRetention time and measured mass confirm the sequence

Storage, Handling and Analytical Verification

Identity and purity are assessed with a small set of standard peptide methods. Reversed-phase high-performance liquid chromatography separates the main peak from truncated or oxidized species, and its area percentage is the usual purity measure. Mass spectrometry confirms the observed molecular mass against the expected value, while amino acid analysis or peptide mapping checks composition and sequence. Specifications for research-grade material are often stated as 95 percent or higher, though the exact limit depends on the supplier and the intended use.

Laboratory supplies of the peptide usually arrive as a lyophilized powder in sealed vials. The powder is hygroscopic, so a vial should be allowed to reach room temperature before it is opened to prevent condensation on the contents. Weighing and transfer are best performed in a low-humidity environment with clean tools. Once dissolved, the solution should be mixed gently rather than vortexed, because foaming and shear can reduce recovery of the peptide.

Storage recommendations center on low temperature, dryness, and protection from repeated freezing and thawing. The intact powder is commonly held at 20 degrees below zero Celsius or colder, while a working solution is divided into single-use aliquots to limit freeze-thaw cycles. Buffered saline or phosphate-buffered saline at neutral pH is frequently used as a diluent. Light sensitivity is not well documented, yet amber vials or foil wrapping are common practice for long-term storage of peptide stocks.

Related pages on this site

Molecular Identity Of Thymosin Alpha-1

Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.

Thymosin alpha-1 is a synthetic peptide of 28 amino acids whose sequence matches the amino-terminal region of prothymosin alpha. The chain is acetylated at its first residue and contains one disulfide bridge between two cysteine residues, which folds the molecule into a compact loop. Its molecular formula, C129H215N33O55, corresponds to a monoisotopic mass of roughly 3,106 daltons. Material used in laboratories is made by solid-phase synthesis rather than isolated from animal tissue.

Early work on thymic extracts in the 1960s described a heat-stable acidic fraction containing many polypeptides. Separation of that mixture yielded individual components, and thymosin alpha-1 was named as one of them on the basis of assays for T-cell activity. The first preparations came from calf thymus, while subsequent research and clinical material has been chemically synthesized. Nomenclature in older papers is inconsistent, and the same peptide sometimes appears under different designations, which complicates literature searches.

Background from the literature

== Sequels and prequel == A sequel, titled Underworld: Evolution, in which Marcus fully awakens, was released January 20, 2006. The prequel Underworld: Rise of the Lycans, which gives more detail about the creation of the Lycan species and Lucian's hatred, was released January 23, 2009. A second sequel, Underworld: Awakening, was released on January 20, 2012, and a third sequel, Underworld: Blood Wars, was released on January 6, 2017.

==== Correspondence to clinical effects ==== Ziprasidone mostly affects the receptors of dopamine (D2), serotonin (5-HT2A, partially 5-HT1A, 5-HT2C, and 5-HT1D) and epinephrine/norepinephrine (α1) to a high degree, while of histamine (H1) - moderately. It also somewhat inhibits reuptake of serotonin and norepinephrine, though not dopamine. Ziprasidone's efficacy in treating the positive symptoms of schizophrenia is believed to be mediated primarily via antagonism of the dopamine receptors, specifically D2. Blockade of the 5-HT2A receptor may also play a role in its effectiveness against positive symptoms, though the significance of this property in antipsychotic drugs is still debated among researchers. Blockade of 5-HT2A and 5-HT2C and activation of 5-HT1A as well as inhibition of the reuptake of serotonin and norepinephrine may all contribute to its ability to alleviate negative symptoms.; however, its effects on the 5-HT1A receptor may be limited as a study found ziprasidone would likely "produce detectable occupancy [of 5-HT1A receptors] only at higher doses that would produce unacceptable levels of side effects in man, although lower doses are sufficient to produce pharmacological effects." The relatively weak antagonistic actions of ziprasidone on the α1-adrenergic receptor likely in part explains some of its side effects, such as orthostatic hypotension. Unlike many other antipsychotics, ziprasidone has no significant affinity for the mACh receptors, and as such lacks any anticholinergic side effects.

=== Mislabeling and adulteration === While many of the claims are based on scientifically based physiological or biochemical processes, their use in bodybuilding parlance is often heavily colored by bodybuilding lore and industry marketing and, as such, may deviate considerably from traditional scientific usages of the terms. In addition, ingredients listed have been found at times to be different from the contents. In 2015, Consumer Reports reported unsafe levels of arsenic, cadmium, lead, and mercury in several of the protein powders that were tested. In the United States, the manufacturers of dietary supplements do not need to provide the Food and Drug Administration with evidence of product safety prior to marketing. As a result, the incidence of products adulterated with illegal ingredients has continued to rise. In 2013, one-third of the supplements linked to liver damage in one study were adulterated with unlisted steroids. More recently, the prevalence of designer steroids with unknown safety and pharmacological effects has increased. In 2015, a CBC investigative report found that protein spiking (i.e., the addition of amino-acid filler to manipulate analysis) was not uncommon; however, many of the companies involved challenged these claims.

== Genetic methods == Experimental analysis of proteins typically requires expression and purification of proteins. Expression is achieved by manipulating DNA that encodes the protein(s) of interest. Hence, protein analysis usually requires DNA methods, especially cloning. Some examples of genetic methods include conceptual translation, Site-directed mutagenesis, using a fusion protein, and matching allele with disease states. Some proteins have never been directly sequenced, however by translating codons from known mRNA sequences into amino acids by a method known as conceptual translation. (See genetic code.) Site-directed mutagenesis selectively introduces mutations that change the structure of a protein. The function of parts of proteins can be better understood by studying the change in phenotype as a result of this change. Fusion proteins are made by inserting protein tags, such as the His-tag, to produce a modified protein that is easier to track. An example of this would be GFP-Snf2H which consists of a protein bound to a green fluorescent protein to form a hybrid protein. By analyzing DNA alleles can be identified as being associated with disease states, such as in calculation of LOD scores.

After the 1921 season, the East Melbourne Cricket Ground was closed and demolished to expand the Flinders Street Railyard. Having played at the East Melbourne Cricket Ground from 1882 to 1921, and having won four VFA premierships (1891–1894) and four VFL premierships (1897, 1901, 1911 and 1912) while there, Essendon was looking for a new home. It was offered grounds at the current Royal Melbourne Showgrounds, Ascot Vale; at Victoria Park, Melbourne; at Arden St, North Melbourne; and the Essendon Cricket Ground. The Essendon City Council offered the (VFL) team the Essendon Cricket Ground, announcing that it would be prepared to spend over £12,000 (equivalent to A$2,159,104 in 2022) on improvements, including a new grandstand, scoreboard and re-fencing of the oval. The club's first preference was to move to North Melbourne—a move which the North Melbourne Football Club (then in the VFA) saw as an opportunity to get into the VFL. Most of Essendon's members and players were from the North Melbourne area, and sportswriters believed that Essendon would have been taken over by or rebranded as North Melbourne within only a few years of the move. However, the VFA, desperate for its own strategic reasons not to lose its use of the North Melbourne Cricket Ground, successfully appealed to the State Government to block Essendon's move to North Melbourne. With its preferred option off the table, the club returned to Essendon, and the Essendon VFA club disbanded, with most of its players moving to North Melbourne.

Sources: en.wikipedia.org

Further detail

Facial amputations include but are not limited to: amputation of the ears amputation of the nose (rhinotomy) amputation of the tongue (glossectomy) amputation of the eyes (enucleation) amputation of the teeth (Dental evulsion). Removal of teeth, mainly incisors, is or was practiced by some cultures for ritual purposes (for instance in the Iberomaurusian culture of Neolithic North Africa). Breasts: amputation of the breasts (mastectomy) Genitals: amputation of the testicles (orchiectomy) amputation of the penis (penectomy) amputation of the foreskin (circumcision) amputation of the clitoris (clitoridectomy) amputation of the vulva (vulvectomy) Radicals: Amputation of the waist (hemicorporectomy) Amputation of the head (decapitation) Genital modification and mutilation may involve amputating tissue, although not necessarily as a result of injury or disease. Laryngectomy is the amputation of the larynx.

ATP is the phosphorylated version of adenosine diphosphate (ADP), which stores energy in a cell and powers most cellular activities. ATP is the energized form, while ADP is the (partially) depleted form. NADP+ is an electron carrier which ferries high energy electrons. In the light reactions, it gets reduced, meaning it picks up electrons, becoming NADPH.

Silent narration This style of narration uses title screens to visually narrate the documentary. The screens are held for about 5–10 seconds to allow adequate time for the viewer to read them. They are similar to the ones shown at the end of movies based on true stories, but they are shown throughout, typically between scenes.

== Regulatory status == The regulatory status of theanine varies by country. It is sold as a dietary supplement across the United States and European Union. In Japan, L-theanine has been approved for use in all foods, with some restrictions in the case of infant foods. In the United States, the FDA considers it to be generally recognized as safe (GRAS) and allows its use as an ingredient in foods and beverages up to a maximum of 250 mg per serving. In 2003, the German Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung, BfR), an agency of their Federal Ministry of Food and Agriculture, objected to the addition of isolated theanine to beverages. While it was estimated the quantity of green tea consumed by the average Japanese tea drinker per day contains about 20 mg of the substance, there were no studies measuring the amount of theanine being extracted by typical preparation methods, or the percentage lost by discarding the first infusion. Therefore, with the Japanese being exposed to possibly much less than 20 mg per day, it was the opinion of the BfR that pharmacological reactions to drinks typically containing 50 mg of theanine per 500 milliliters could not be excluded –reactions such as impairment of psychomotor skills and amplification of the sedating effects of alcohol and hypnotics.

Catatonia, on the other hand, is associated with normal EEG or diffuse slowing. Delirium is characterized by fluctuating disturbed perception and consciousness in the ill individual. It has hypoactive and hyperactive or mixed forms. People with hyperactive delirium present similarly to those with excited catatonia and have symptoms of restlessness, agitation, and aggression. Those with hypoactive delirium present with similarly to stuporous catatonia, withdrawn and quiet. However, catatonia also includes other distinguishing features including posturing and rigidity as well as a positive response to benzodiazepines. Patients with locked-in syndrome present with immobility and mutism; however, unlike patients with catatonia who are unmotivated to communicate, patients with locked-in syndrome try to communicate with eye movements and blinking. Furthermore, locked-in syndrome is caused by damage to the brainstem. Stiff-person syndrome and catatonia are similar in that they may both present with rigidity, autonomic instability, and a positive response to benzodiazepines. However, stiff-person syndrome may be associated with anti-glutamic acid decarboxylase (anti-GAD) antibodies and other catatonic signs such as mutism and posturing are not part of the syndrome. Untreated late-stage Parkinson's disease may present similarly to stuporous catatonia with symptoms of immobility, rigidity, and difficulty speaking.

Sources: en.wikipedia.org

Background from the literature

Sandra Ferry Rockefeller (1935–2024) John Davison "Jay" Rockefeller IV – a former U.S. Senator from West Virginia and a former two-term governor of that state Hope Aldrich Rockefeller Alida Ferry Rockefeller

For type II and inverse type II dots, either the conduction or valence band of the core is located within the bandgap of the shell, which can lead to spatial separation of charge carriers in the core and shell. For all of these core/shell systems, the deposition of the outer layer can lead to potential lattice mismatch, which can limit the ability to grow a thick shell without reducing photoluminescent performance. One such reason for the decrease in performance can be attributed to the physical strain being put on the lattice. In a case where ZnSe/ZnS (type I) and ZnSe/CdS (type II) quantum dots were being compared, the diameter of the uncoated ZnSe core (obtained using TEM) was compared to the capped core diameter (calculated via effective mass approximation model) [lattice strain source] to better understand the effect of core-shell strain. Type I heterostructures were found to induce compressive strain and "squeeze" the core, while the type II heterostructures had the effect of stretching the core under tensile strain. Because the fluorescent properties of quantum dots are dictated by nanocrystal size, induced changes in core dimensions can lead to shifting of emission wavelength, further proving why an intermediate semiconductor layer is necessary to rectify lattice mismatch and improve quantum yield. One such core/double-shell system is the CdSe/ZnSe/ZnS nanocrystal. In a study comparing CdSe/ZnS and CdSe/ZnSe nanocrystals, the former was found to have PL yield 84% of the latter's, due to a lattice mismatch.

== Function == The GLP2 receptor (GLP2R) is a G protein-coupled receptor superfamily member closely related to the glucagon receptor (GLP1 receptor). Glucagon-like peptide-2 (GLP2) is a 33-amino acid proglucagon-derived peptide produced by intestinal enteroendocrine cells. Like glucagon-like peptide-1 (GLP1) and glucagon itself, it is derived from the proglucagon peptide encoded by the GCG gene. GLP2 stimulates intestinal growth and upregulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. Moreover, GLP2 prevents intestinal hypoplasia resulting from total parenteral nutrition. GLP2R, a G protein-coupled receptor superfamily member is expressed in the gut and closely related to the glucagon receptor (GCGR) and the receptor for GLP1 (GLP1R).

Mahathir criticised the awarding of import permits for foreign cars, which he claimed were causing Proton's domestic sales to suffer, and attacked Abdullah for cancelling the construction of a second causeway between Malaysia and Singapore. Mahathir complained that his views were not getting sufficient airing by the Malaysian press. In response, he began writing a column for Malaysiakini and starting his own blog. He unsuccessfully sought election from his local party division to be a delegate to UMNO's general assembly in 2006, where he planned to initiate a challenge to Abdullah's leadership. Mahathir had previously missed the UMNO General Assembly twice since 2006 for health reasons. After the 2008 election, in which UMNO lost its two-thirds majority in parliament, Mahathir resigned from the party. When Abdullah was replaced by his deputy Najib Razak in 2009, Mahathir re-joined the party and urged all former members to follow his move. Before the 2013 general election, Mahathir promised to keep the government in check and ensure it fulfilled its manifesto promises, vowing to protest and fight against it if it failed.

The modifications described here cover alterations to the ring structure donated by the fentanyl precursor 4-ANPP. Although another series covered substitutions of hydrogen atoms on the original carbon ring structure, sometimes called functional group additions, this series focuses on the three main modifications to the phenethyl moiety. The first modifications is the removal of the phenethyl moeity from the piperidinyl nitrogen, depicted here as hydrolysis yielding phenethanol. This changes the parent skeletal name to norfentanyl. The second and third modifications are the removal and addition of a methylene moiety internally in the ethyl chain within the greater phenethyl moiety. The removal of a methylene, which shortens the chain by one carbon length, creates the benzylfentanyl structure. The addition of a methylene, which lengthens the chain by one length, creates homofentanyl.

Sources: en.wikipedia.org

Frequently asked questions

What is thymosin alpha 1?

It is a 28-amino-acid peptide originally purified from a bovine thymic extract and later produced synthetically. It is studied mainly for its effects on immune cell function.

Is thymosin alpha 1 the same as thymosin beta 4?

No. The two peptides share part of a name but differ in length, sequence, and net charge. Literature searches that treat them as one compound return misleading results.

How is the peptide obtained for laboratory work?

Solid-phase peptide synthesis is the usual route, and recombinant expression has also been described. Both approaches produce material matching the natural sequence.

胸腺素α1是激素吗?

它不是经典的内分泌激素,而是一种免疫调节肽。其作用主要通过局部免疫细胞间的信号传递实现,而非经血液循环作用于远隔器官。

Network